Letter to new shareholders - election of means of receipt of corporate communications

(Incorporated in Hong Kong with limited liability) （于香港注册成立的有限公司） (Stock Code: 3320) （股份代号：3320） 12 July 2024 Dear Shareholders Letter to new shareholders — election of means of receipt of corporate communications In order to protect the environment China Resources Pharmaceutical Group Limited (the “Company”) proposes that as a shareholder of the Company you may choose to receive its Corporate CommunicationsNote: (i) by electronic means through the Company’s website at http://www.crpharm.com (the “Electronic Communication Option”); or (ii) in printed form.The purpose of this letter is to ascertain shareholders’ choice of means of receipt of Corporate Communications.Please kindly complete Part B of the attached Instruction Slip and return the completed Instruction Slip to the Company’s Share Registrar Tricor Investor Services Limited by facsimile at (852) 2861 1465 by email at crpharm-3320@hk.tricorglobal.com or by post using the mailing label provided.If you elect the Electronic Communication Option and have specified your email address in the Instruction Slip we will send you on the day of issue an email notification each time new Corporate Communications are posted on the Company’s website above-mentioned. In case you have not provided your email address we will notify you by mail instead.Please note that you may change your choice of means of receipt (whether by positive consent or by deemed consent) at any time free of charge by giving reasonable prior notice by completing and returning to the Company’s Share Registrar the Instruction Slip using any of the above-mentioned methods. A copy of the Instruction Slip will be sent to you together with future Corporate Communications or can be obtained from the Company’s Share Registrar.Shareholders who have opted for the Electronic Communication Option and who for any reason have difficulty in receiving or gaining access to the relevant Corporate Communications will upon request in writing to the Company’s Share Registrar using any of the above-mentioned methods be promptly sent such Corporate Communications in printed form free of charge.Should you have any queries relating to this letter please call our Share Registrar’s investor services hotline at (852) 2980 1333 from 9:00 a.m.to 5:00 p.m. Monday to Friday (excluding public holidays).Yours faithfully For and on behalf of China Resources Pharmaceutical Group Limited Han Yuewei Chairman Encl.Note: Corporate Communications refer to any document issued or to be issued by the Company for information or action of holders of securities of the Company including but not limited to annual report summary financial report (where applicable) interim report summary interim report (where applicable) notice of meeting listing document circular and proxy form.敬启者： 致新股东之函件—选择收取公司通讯的形式 为 支 持 环 保，华 润 医 药 集 团 有 限 公 司（「本 公 司」）建 议 阁 下 作 为 本 公 司 股 东 可 以 选 择：(i)透 过 本 公 司 的 网 站(http://www.crpharm.com )以电子形式浏览公司通讯注（「电子通讯选择权」）；或 (ii)收取公司通讯之印刷本。 现谨奉函向股东确定选择收取公司通讯的方式。 请 阁下填妥随附指示回条乙部，并将已填妥之指示回条传真至 (852) 2861 1465、电邮至 crpharm-3320@hk.tricorglobal.com或利用邮寄标签寄回本公司股份过户登记处卓佳证券登记有限公司。 如阁下选择电子通讯选择权并已在指示回条内注明阁下之电邮地址，我们将会在每次有新的公司通讯在上述本公司的网站登载时，于该公司通讯发出当日以电邮方式通知阁下。倘阁下未有提供电邮地址，本公司将会以邮寄方式知会阁下。 请注意阁下可以给予合理时间的通知随时透过填写指示回条（该指示回条将连同日后的公司通讯一并寄予阁下，或可向本公司股份过户登记处索取）更改已选择的收取方式（不论是正面同意或是被视为同意的情况），费用全免。填妥的指示回条须透过上述任何一种方式交回本公司股份过户登记处。 已选择电子通讯选择权的股东，如因任何理由以致收取或接收有关公司通讯上出现困难，只要透过上述任何一种方式向本公司股份过户登记处提出书面要求，均可立即获免费发送该公司通讯的印刷本。 倘阁下对本函件有任何疑问，请于星期一至星期五（公众假期除外）上午9时至下午5时致电本公司股份过户登记处的投资者服务热线(852)29801333。 此致列位股东台照代表华润医药集团有限公司韩跃伟主席谨启二零二四年七月十二日附件 注：公司通讯指由本公司发出或将予发出以供本公司证券持有人参照或采取行动的任何文件，其中包括但不限于年报、财务摘要报告（如适用）、中期报告、中期摘要报告（如适用）、会议通告、上市文件、通函及代表委任表格。INSTRUCTION SLIP 指示回条(Incorporated in Hong Kong with limited liability)（于香港注册成立的有限公司） (Stock Code: 3320)（股份代号：3320） Please complete sign and return this instruction slip to the Share Registrar of China Resources Pharmaceutical Group Limited (the “Company”) Tricor Investor Services Limited by facsimile at (852) 2861 1465 by email at crpharm-3320@hk.tricorglobal.com or by post using the mailing label provided.请填妥及签署下列指示回条， 并传真至 (852) 2861 1465、电邮至 crpharm-3320@hk.tricorglobal.com或利用邮寄标签寄回华润医药集团有限公司（「本公司」）股份过户登记处卓佳证券登记有限公司。 Part A — To receive a printed version of the Circular dated 12 July 2024 and Proxy form for use at the 2024 first extraordinary general meeting on 31 July 2024 (the “Enclosed Document”):甲部—收取日期为二零二四年七月十二日的通函及用于二零二四年七月三十一日之二零二四年第一次股东特别大会的代表委任表格（「随附文件」）之印刷本： I/We have chosen to receive the Enclosed Document by electronic means through the Company’s website but would like to receive them in printed form.本人╱吾等已选择透过本公司的公司网站以电子方式浏览随附文件，但希望收取其印刷本。 Part B — To elect/change the means of receipt of future Corporate Communications*: 乙部—选择╱更改日后收取公司通讯*之形式： I/We would like to receive all future Corporate Communications of the Company: 关于本公司日后发布的所有公司通讯，本人╱吾等欲： (Please tick only one box（) 只可选择一项，请于以下适当的空格加上「 」号）in printed form; or只收取印刷本；或 by electronic means in lieu of printed form.以电子方式取代印刷本。 My/Our email address: 本人╱吾等的电邮地址： (Please ensure your email address is properly filled in for the purpose of receiving the notification of release of Corporate Communications)（请确保填上正确的电邮地址以作收取公司通讯发布的通知之用） Name(s) of Shareholder(s) in English (Please use BLOCK LETTERS) Name(s) of Shareholder(s) in Chinese 股东的英文名称（请以大楷书写）股东的中文名称 Registered Address of Shareholder(s)股东的登记地址 Contact Telephone Number Signature(s) Date联络电话签署日期 Notes: 1. The above instruction will apply to all Corporate Communications to be sent to you until you inform us otherwise. 2. If any shares are held in joint names all joint holders OR the joint holder whose name stands first on the register of members of the Company should sign this form in order for it to be valid. 3. This instruction slip with no box ticked with more than one box ticked or otherwise incorrectly completed will be voided at the discretion of the Company. 4. Printed versions of all future Corporate Communications of the Company will be available on request in writing to the Share Registrar of the Company. Such Corporate Communications will also be available on the Company’s website at http://www.crpharm.com.* Corporate Communications refer to any document issued or to be issued by the Company for information or action of holders of securities of the Company including but not limited to annual report summary financial report (where applicable) interim report summary interim report (where applicable) notice of meeting listing document circular and proxy form.注：1.上述指示将适用于本公司将会发送给阁下的所有公司通讯文件，直至阁下另行通知为止。 2.如任何股份以联名方式持有，则所有联名持有人或名列本公司股东名册的首名联名持有人须于本表格上签署，方为有效。 3.如未有在任何上述适当空格加上「」号，或在超过一个空格加上「」号，或在其他方面填写不正确，本公司可酌情决定将本指示回条作废。 4. 本公司日后所有公司通讯的印刷本，可透过书面通知向本公司股份过户登记处索取。该等公司通讯文件亦登载于本公司网站 (http://www.crpharm.com )。 *公司通讯指由本公司发出或将予发出以供本公司证券持有人参照或采取行动的任何文件，其中包括但不限于年报、财务摘要报告（如适用）、中期报告、中期摘要报告（如适用）、会议通告、上市文件、通函及代表委任表格。 Mailing Label 邮寄标签 Please cut the mailing label and stick this on Tricor Investor Services Limited an envelope to return the Instruction Slip to us. 卓佳证券登记有限公司 No postage stamp is required for local mailing 当 阁下寄回此指示回条时，请将此邮寄标签剪贴于信封上。 Freepost No. 简便回邮号码：10 GPO如在本港投寄， 阁下无需支付邮费或贴上邮票 Hong Kong 香港